Interpretation of lung function in infants and young children with cystic fibrosis

Respirology

Volumn 19, Issue 6, 2014, Pages 792-799

  Ramsey, Kathryn A ^a   Ranganathan, Sarath ^b,c,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cystic fibrosis; infection and inflammation; paediatric lung disease; respiratory function test; respiratory structure and function

Indexed keywords

LEUKOCYTE ELASTASE;

AIRWAY REMODELING; CLINICAL PRACTICE; CYSTIC FIBROSIS; DISEASE COURSE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; INFANT; LUNG DEVELOPMENT; LUNG FUNCTION; LUNG FUNCTION TEST; MULTIPLE BREATH INERT GAS WASHOUT; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY TRACT PARAMETERS; REVIEW; AGE; BREATH ANALYSIS; CHILD; LUNG; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SPIROMETRY;

AGE FACTORS; BREATH TESTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HUMANS; INFANT; INFANT, NEWBORN; LUNG; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 84904540961     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12329     Document Type: Review

References (92)

1. Sturgess J, Imrie J,. Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis and control infants. Am. J. Pathol. 1982; 106: 303-311.
2. Sly PD, Brennan S, Gangell C, de Klerk N, Murray C, Mott L, Stick SM, Robinson PJ, Robertson CF, Ranganathan SC,. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am. J. Respir. Crit. Care Med. 2009; 180: 146-152.
3. Stick SM, Brennan S, Murray C, Douglas T, von Ungern-Sternberg BS, Garratt LW, Gangell CL, De Klerk N, Linnane B, Ranganathan S, et-al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J. Pediatr. 2009; 155: 623-628, e1.
4. Adam RJ, Michalski AS, Bauer C, Abou Alaiwa MH, Gross TJ, Awadalla MS, Bouzek DC, Gansemer ND, Taft PJ, Hoegger MJ, et-al. Air trapping and airflow obstruction in newborn cystic fibrosis piglets. Am. J. Respir. Crit. Care Med. 2013; 188: 1434-1441.
5. Meyerholz DK, Stoltz DA, Namati E, Ramachandran S, Pezzulo AA, Smith AR, Rector MV, Suter MJ, Kao S, McLennan G, et-al. Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children. Am. J. Respir. Crit. Care Med. 2010; 182: 1251-1261.
6. Mott LS, Park J, Murray CP, Gangell CL, de Klerk NH, Robinson PJ, Robertson CF, Ranganathan SC, Sly PD, Stick SM,. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012; 67: 509-516.
7. Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A,. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 2008; 63: 129-134.
8. Owens CM, Aurora P, Stanojevic S, Bush A, Wade A, Oliver C, Calder A, Price J, Carr SB, Shankar A,. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 2011; 66: 481-488.
9. Wainwright CE, Vidmar S, Armstrong DS, Byrnes CA, Carlin JB, Cheney J, Cooper PJ, Grimwood K, Moodie M, Robertson CF,. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial. JAMA 2011; 306: 163-171.
10. Ranganathan S, Gappa M,. Which test is best: cystic fibrosis. Eur. Respir. Mon. 2010; 47: 225-239.
11. Lum SL, Stocks J, Castile R, Davis S, Henschen M, Jones M, Morris MG, Ranganathan S, Sly P, Tepper RS,. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am. J. Respir. Crit. Care Med. 2005; 172: 1463-1471.
12. Ranganathan SC, Bush A, Dezateux C, Carr SB, Hoo AF, Lum S, Madge S, Price J, Stroobant J, Wade A, et-al. Relative ability of full and partial forced expiratory maneuvers to identify diminished airway function in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2002; 166: 1350-1357.
13. Turner DJ, Lanteri CJ, LeSouef PN, Sly PD,. Improved detection of abnormal respiratory function using forced expiration from raised lung volume in infants with cystic fibrosis. Eur. Respir. J. 1994; 7: 1995-1999.
14. Burger EJ Jr, Macklem P,. Airway closure: demonstration by breathing 100 percent O2 at low lung volumes and by N2 washout. J. Appl. Physiol. 1968; 25: 139-148.
15. Gustafsson PM, Kallman S, Ljungberg H, Lindblad A,. Method for assessment of volume of trapped gas in infants during multiple-breath inert gas washout. Pediatr. Pulmonol. 2003; 35: 42-49.
16. Schibler A, Schneider M, Frey U, Kraemer R,. Moment ratio analysis of multiple breath nitrogen washout in infants with lung disease. Eur. Respir. J. 2000; 15: 1094-1101.
17. Lum S, Gustafsson P, Ljungberg H, Hulskamp G, Bush A, Carr SB, Castle R, Hoo AF, Price J, Ranganathan S, et-al. Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax 2007; 62: 341-347.
18. Ranganathan SC, Dezateux C, Bush A, Carr SB, Castle RA, Madge S, Price J, Stroobant J, Wade A, Wallis C, et-al. Airway function in infants newly diagnosed with cystic fibrosis. Lancet 2001; 358: 1964-1965.
19. Ranganathan SC, Stocks J, Dezateux C, Bush A, Wade A, Carr S, Castle R, Dinwiddie R, Hoo AF, Lum S, et-al. The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am. J. Respir. Crit. Care Med. 2004; 169: 928-933.
20. Hoo AF, Thia LP, Nguyen TT, Bush A, Chudleigh J, Lum S, Ahmed D, Balfour Lynn I, Carr SB, Chavasse RJ, et-al. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax 2012; 67: 874-881.
21. Linnane BM, Hall GL, Nolan G, Brennan S, Stick SM, Sly PD, Robertson CF, Robinson PJ, Franklin PJ, Turner SW, et-al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am. J. Respir. Crit. Care Med. 2008; 178: 1238-1244.
22. Pillarisetti N, Williamson E, Linnane B, Skoric B, Robertson CF, Robinson P, Massie J, Hall GL, Sly P, Stick S, et-al. Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2011; 184: 75-81.
23. Peterson-Carmichael SL, Harris WT, Goel R, Noah TL, Johnson R, Leigh MW, Davis SD,. Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis. Pediatr. Pulmonol. 2009; 44: 503-511.
24. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K, Wainwright C,. Early airway infection, inflammation, and lung function in cystic fibrosis. Arch. Dis. Child. 2002; 87: 306-311.
25. Belessis Y, Dixon B, Hawkins G, Pereira J, Peat J, MacDonald R, Field P, Numa A, Morton J, Lui K, et-al. Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index. Am. J. Respir. Crit. Care Med. 2012; 185: 862-873.
26. Martinez TM, Llapur CJ, Williams TH, Coates C, Gunderman R, Cohen MD, Howenstine MS, Saba O, Coxson HO, Tepper RS,. High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2005; 172: 1133-1138.
27. Hall GL, Logie KM, Parsons F, Schulzke SM, Nolan G, Murray C, Ranganathan S, Robinson P, Sly PD, Stick SM, et-al. Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening. PLoS ONE 2011; 6: e23932.
28. Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD,. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012; 307: 2269-2277.
29. Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M, Davis S, Brumback L, Gustafsson P, Ratjen F,. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. Am. J. Respir. Crit. Care Med. 2013; 188: 456-460.
30. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HGM, Aurora P, Bisgaard H, Davis GM, Ducharme FM, Eigen H, et-al. An official american thoracic society/european respiratory society statement: pulmonary function testing in preschool children. Am. J. Respir. Crit. Care Med. 2007; 175: 1304-1345.
31. Singer F, Houltz B, Latzin P, Robinson P, Gustafsson P,. A realistic validation study of a new nitrogen multiple-breath washout system. PLoS ONE 2012; 7: e36083.
32. Gustafsson PM, Aurora P, Lindblad A,. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur. Respir. J. 2003; 22: 972-979.
33. Kerby GS, Rosenfeld M, Ren CL, Mayer OH, Brumback L, Castile R, Hart MA, Hiatt P, Kloster M, Johnson R, et-al. Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting. Pediatr. Pulmonol. 2012; 47: 597-605.
34. Marostica PJ, Weist AD, Eigen H, Angelicchio C, Christoph K, Savage J, Grant D, Tepper RS,. Spirometry in 3- to 6-year-old children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2002; 166: 67-71.
35. VanDevanter DR, Pasta DJ,. Evidence of diminished FEV1 and FVC in 6-year-olds followed in the European cystic fibrosis patient registry, 2007-2009. J. Cyst. Fibros. 2013; 12: 786-789.
36. Aurora P, Bush A, Gustafsson P, Oliver C, Wallis C, Price J, Stroobant J, Carr S, Stocks J,. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2005; 171: 249-256.
37. Aurora P,. Multiple-breath inert gas washout test and early cystic fibrosis lung disease. Thorax 2010; 65: 373-374.
38. Brumback LC, Davis SD, Kerby GS, Kloster M, Johnson R, Castile R, Hiatt PW, Hart M, Rosenfeld M,. Lung function from infancy to preschool in a cohort of children with cystic fibrosis. Eur. Respir. J. 2013; 41: 60-66.
39. Kozlowska WJ, Bush A, Wade A, Aurora P, Carr SB, Castle RA, Hoo AF, Lum S, Price J, Ranganathan S, et-al. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 42-49.
40. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et-al. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319-338.
41. Kerem E, Reisman J, Corey M, Canny GJ, Levison H,. Prediction of mortality in patients with cystic fibrosis. N. Engl. J. Med. 1992; 326: 1187-1191.
42. Nielsen KG, Pressler T, Klug B, Koch C, Bisgaard H,. Serial lung function and responsiveness in cystic fibrosis during early childhood. Am. J. Respir. Crit. Care Med. 2004; 169: 1209-1216.
43. Henry RL, Gibson PG, Carty K, Cai Y, Francis JL,. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis. Pediatr. Pulmonol. 1998; 26: 97-100.
44. Regelmann WE, Siefferman CM, Herron JM, Elliott GR, Clawson CC, Gray BH,. Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis. Pediatr. Pulmonol. 1995; 19: 1-9.
45. Sagel SD, Sontag MK, Wagener JS, Kapsner RK, Osberg I, Accurso FJ,. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis. J. Pediatr. 2002; 141: 811-817.
46. Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Makholm LM, Rock MJ, Splaingard ML,. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr. Pulmonol. 2003; 36: 230-240.
47. Jacques I, Derelle J, Weber M, M, Vidailhet M,. Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur. J. Pediatr. 1998; 157: 427-431.
48. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K,. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J. Pediatr. 2001; 138: 699-704.
49. Pamukcu A, Bush A, Buchdahl R,. Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr. Pulmonol. 1995; 19: 10-15.
50. Kraemer R, Baldwin DN, Ammann RA, Frey U, Gallati S,. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis. Respir. Res. 2006; 7: 138.
51. Kraemer R, Delosea N, Ballinari P, Gallati S, Crameri R,. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2006; 174: 1211-1220.
52. Singer F, Kieninger E, Abbas C, Yammine S, Fuchs O, Proietti E, Regamey N, Casaulta C, Frey U, Latzin P,. Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting. Pediatr. Pulmonol. 2013; 48: 739-746.
53. Ellemunter H, Fuchs SI, Unsinn KM, Freund MC, Waltner-Romen M, Steinkamp G, Gappa M,. Sensitivity of Lung Clearance Index and chest computed tomography in early CF lung disease. Respir. Med. 2010; 104: 1834-1842.
54. Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev KM, Borowitz D, Bowman CM, Marshall BC, et-al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N. Engl. J. Med. 1999; 340: 23-30.
55. Redding GJ, Restuccia R, Cotton EK, Brooks JG,. Serial changes in pulmonary functions in children hospitalized with cystic fibrosis. Am. Rev. Respir. Dis. 1982; 126: 31-36.
56. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME,. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N. Engl. J. Med. 1994; 331: 637-642.
57. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT,. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N. Engl. J. Med. 2006; 354: 229-240.
58. Horsley AR, Davies JC, Gray RD, Macleod KA, Donovan J, Aziz ZA, Bell NJ, Rainer M, Mt-Isa S, Voase N, et-al. Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 2013; 68: 532-539.
59. Amin R, Subbarao P, Lou W, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F,. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur. Respir. J. 2011; 37: 806-812.
60. Amin R, Subbarao P, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F, et-al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010; 65: 379-383.
61. Davies J, Sheridan H, Bell NJ, Cunningham S, Davis S, Elborn J, Milla CE, Starner TD, Weiner DJ, Lee P, et-al. Assessment of clinical response to ivacaftor with lung clearance index in cystic fi brosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial in patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. Lancet Respir. Med. 2013; 1: 630-638.
62. Robinson PD, Cooper P, Van Asperen P, Fitzgerald D, Selvadurai H,. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis. Pediatr. Pulmonol. 2009; 44: 733-742.
63. Yammine S, Bigler A, Casaulta C, Singer F, Latzin P,. Reasons for heterogeneous change in LCI in children with cystic fibrosis after antibiotic treatment. Thorax 2014; 69: 183.
64. Welsh L, Tomai M, Tran H, Ranganathan S,. Lung Clearance Index during Pulmonary Exacerbation in School-age Children with Cystic Fibrosis. European Respiratory Society Annual Congress, Barcelona Spain, 2013.
65. Harrison AN, Regelmann WE, Zirbes JM, Milla CE,. Longitudinal assessment of lung function from infancy to childhood in patients with cystic fibrosis. Pediatr. Pulmonol. 2009; 44: 330-339.
66. Kraemer R, Blum A, Schibler A, Ammann RA, Gallati S,. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2005; 171: 371-378.
67. Hayllar KM, Williams SG, Wise AE, et-al. A prognostic model for the prediction of survival in cystic fibrosis. Thorax 1997; 52: 313-317.
68. Kieninger E, Singer F, Fuchs O, Abbas C, Frey U, Regamey N, Casaulta C, Latzin P,. Long-term course of lung clearance index between infancy and school-age in cystic fibrosis subjects. J. Cyst. Fibros. 2011; 10: 487-490.
69. Aurora P, Stanojevic S, Wade A, Oliver C, Kozlowska W, Lum S, Bush A, Price J, Carr SB, Shankar A, et-al. Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2011; 183: 752-758.
70. Vermeulen F, Proesmans M, Boon M, Havermans T, De Boeck K,. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis. Thorax 2014; 69: 39-45.
71. Beardsmore CS,. Lung function from infancy to school age in cystic fibrosis. Arch. Dis. Child. 1995; 73: 519-523.
72. Beardsmore CS, Bar-Yishay E, Maayan C, Yahav Y, Katznelson D, Godfrey S,. Lung function in infants with cystic fibrosis. Thorax 1988; 43: 545-551.
73. Godfrey S, Mearns M, Howlett G,. Serial lung function studies in cystic fibrosis in the first 5 years of life. Arch. Dis. Child. 1978; 53: 83-85.
74. Phelan PD, Gracey M, Williams HE, Anderson CM,. Ventilatory function in infants with cystic fibrosis. Physiological assessment of halation therapy. Arch. Dis. Child. 1969; 44: 393-400.
75. Tepper RS, Hiatt P, Eigen H, Scott P, Grosfeld J, Cohen M,. Infants with cystic fibrosis: pulmonary function at diagnosis. Pediatr. Pulmonol. 1988; 5: 15-18.
76. Tepper RS, Montgomery GL, Ackerman V, Eigen H,. Longitudinal evaluation of pulmonary function in infants and very young children with cystic fibrosis. Pediatr. Pulmonol. 1993; 16: 96-100.
77. Aurora P, Kozlowska W, Stocks J,. Gas mixing efficiency from birth to adulthood measured by multiple-breath washout. Respir. Physiol. Neurobiol. 2005; 148: 125-139.
78. Aurora P, Gustafsson P, Bush A, Lindblad A, Oliver C, Wallis CE, Stocks J,. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004; 59: 1068-1073.
79. Lum S, Stocks J, Stanojevic S, Wade A, Robinson P, Gustafsson P, Brown M, Aurora P, Subbarao P, Hoo AF, et-al. Age and height dependence of lung clearance index and functional residual capacity. Eur. Respir. J. 2013; 41: 1371-1377.
80. Jensen R, Stanojevic S, Gibney K, Salazar JG, Gustafsson P, Subbarao P, Ratjen F,. Multiple breath nitrogen washout: a feasible alternative to mass spectrometry. PLoS ONE 2013; 8: e56868.
81. Robinson PD, Latzin P, Verbanck S, Hall GL, Horsley A, Gappa M, Thamrin C, Arets HG, Aurora P, Fuchs SI, et-al. Consensus statement for inert gas washout measurement using multiple- and single-breath tests. Eur. Respir. J. 2013; 41: 507-522.
82. Ranganathan SC, Hoo AF, Lum SY, Goetz I, Castle RA, Stocks J,. Exploring the relationship between forced maximal flow at functional residual capacity and parameters of forced expiration from raised lung volume in healthy infants. Pediatr. Pulmonol. 2002; 33: 419-428.
83. Ratjen F,. Cystic fibrosis: the role of the small airways. J. Aerosol Med. Pulm. Drug Deliv. 2012; 25: 261-264.
84. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, et-al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr. Pulmonol. 2001; 32: 356-366.
85. Gangell C, Gard S, Douglas T, Park J, de Klerk N, Keil T, Brennan S, Ranganathan S, Robins-Browne R, Sly PD,. Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis. Clin. Infect. Dis. 2011; 53: 425-432.
86. Rayner RJ, Hiller EJ, Ispahani P, Baker M,. Haemophilus infection in cystic fibrosis. Arch. Dis. Child. 1990; 65: 255-258.
87. Amin R, Dupuis A, Aaron SD, Ratjen F,. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 2010; 137: 171-176.
88. Corey M, Edwards L, Levison H, Knowles M,. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J. Pediatr. 1997; 131: 809-814.
89. Davis SD, Rosenfeld M, Kerby GS, Brumback L, Kloster MH, Acton JD, Colin AA, Conrad CK, Hart MA, Hiatt PW, et-al. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am. J. Respir. Crit. Care Med. 2010; 182: 1387-1397.
90. Jones M, Castile R, Davis S, Kisling J, Filbrun D, Flucke R, Goldstein A, Emsley C, Ambrosius W, Tepper RS,. Forced expiratory flows and volumes in infants. Normative data and lung growth. Am. J. Respir. Crit. Care Med. 2000; 161: 353-359.
91. Gaffin JM, Shotola NL, Martin TR, Phipatanakul W,. Clinically useful spirometry in preschool-aged children: evaluation of the 2007 American Thoracic Society Guidelines. J. Asthma 2010; 47: 762-767.
92. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et-al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur. Respir. J. 2012; 40: 1324-1343.